🇺🇸 FDA
Patent

US 11458094

Compositions and methods for treating pulmonary edema or lung inflammation

granted A61KA61K31/198A61K9/0078

Quick answer

US patent 11458094 (Compositions and methods for treating pulmonary edema or lung inflammation) held by Regents of the University of Minnesota expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/198, A61K9/0078, A61P, A61P11/00